Zoetis Stock News

Zoetis, a global leader in the animal health industry, has beaten the S&P 500 over the last five years and offers diverse growth opportunities. The company has a strong international presence, a commi

Zoetis has more than doubled the S&P 500's return over the past decade. The animal health company's return on invested capital has risen to over 18%.

I present my top 15 high-growth dividend stocks to consider during the month of June. The watchlist underperformed VIG in May, but continues to outpace the ETF year-to-date and since inception. Five n

The article discusses Zoetis, a low-yielding dividend stock with high dividend growth potential. Zoetis is the world's leading producer of medicine and vaccinations for pets and livestock, with a glob

Zoetis (ZTS) came out with quarterly earnings of $1.31 per share, beating the Zacks Consensus Estimate of $1.27 per share. This compares to earnings of $1.32 per share a year ago.

Animal health behemoth Zoetis reported a mixed first quarter but kept its full-year outlook. Still, ZTS stock tumbled early Thursday.

The animal health provider maintained its guidance for full year 2023 after first quarter earnings beat expectations.

I present my top 15 high-growth dividend stocks to consider during the month of May. The watchlist posted a gain of 0.41% in April, trailing both VIG and SPY.

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #Fortune500--Zoetis Inc. (NYSE:ZTS) will host an Investor Day on Thursday, May 25, 2023, at the New York Stock Exchange featuring Kristin Peck, Chief Executi

Women hold a tiny fraction of the CEO jobs at America's biggest companies. That number is steadily increasing.

Nearly 87 million households -- over two-thirds of the total -- own at least one pet. Spending on pet healthcare could nearly double by 2030 to $112 billion.

Animal-loving investors may be interested in exploring opportunities in the pet industry. While there are altruistic reasons for supporting companies that focus on the well-being of our furry friends,

Investors interested in Medical - Drugs stocks are likely familiar with Astellas Pharma Inc. (ALPMY) and Zoetis (ZTS). But which of these two stocks presents investors with the better value opportunit

During the pandemic lockdowns, adopting pets became popular, resulting in a whopping 5 million more pets being added to households in the U.S. Morgan Stanley predicts that the overall spending in the

Peter Drucker, who is widely considered the father of modern management, famously said that a business only has two basic functions and Zoetis is thriving on both these fronts. Numbers continue to tre